NCT03210909View on ClinicalTrials.gov

Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

July 20, 2017

Study Completion Date

July 20, 2017

Conditions
Heart Decompensation, Acute
Interventions
DRUG

BMS-986231

BMS-986231

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03210909 - Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants | Biotech Hunter | Biotech Hunter